Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5

Clinical Nephrology

Volumn 70, Issue 4, 2008, Pages 296-305

  Lehmann, Gabriele ^a   Ott, U ^a   Kammerer D ^c   Schutze J ^b   Wolf, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES JENA   (Germany)

^c Central Clinic Bad Berka   (Germany)

Author keywords

Biochemical bone turnover markers; Bone histomorphometry; Renal osteodystrophy

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; DEOXYPYRIDINOLINE; PARATHYROID HORMONE; PYRIDINOLINE;

ACID PHOSPHATASE BLOOD LEVEL; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE BIOPSY; BONE TURNOVER; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; OSTEITIS FIBROSA; PARATHYROID HORMONE BLOOD LEVEL; PREDICTOR VARIABLE; RENAL OSTEODYSTROPHY;

EID: 54949142792     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70296     Document Type: Article

References (34)

1. Asmus HG, Braun J, Krause RD, Brunkhorst R, Holzer H, Schulz W, Neumayer HH, Raggi P, Bommer J. Two-year comparison of sevelamer and calcium carbonate effects on cardiovacsular calcification and bone density. Nephrol Dial Transplant. 2005; 20: 1653-1661.
2. Blumsohn A, Hannon RA, Eastell R. Biochemical assessment of skeletal activity. Phys Med Rehab Clin North Am. 1995; 6: 483-505.
3. Calvo MS, Eyre DR, Grundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev. 1996; 17: 333-368.
4. Cannata Andia JB. Adynamic bone and chronic renal failure: anoverview. Am J Med Sci. 2000; 320: 81-84.
5. Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, Giustini M, Giordano R, Nicolai G, Manni M, Sardella D, Taggi F. Renal osteodystrophy in predialysis and hemodialysis patients. Comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron. 2002; 91: 103-111.
6. Coen G, Mantella D, Manni M, Balducci A, Nofroni I, Sardella D, Ballanti P, Bonucci E. 25-hydroxyvitamin D level and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int. 2005; 68: 1840-1848.
7. Delling G. Endocrine bone diseases, morphology, histomorphometry and differential diagnosis. Veröff Pathol. 1975; 98: 1-111.
8. Denton J, Freemont AJ, Ball J. Detection and distribution of aluminum in bone. J Clin Pathol. 1984; 37: 136-142.
9. Fernandez-Martin JL, Menendez P, Acuna G, Canteros A, Gomez C, Cannata JB. Staining of bone aluminum. Comparison between aluminon and solochrome azurine and their correlation with bone aluminum content. Nephrol Dial Transplant. 1996; 11 (Suppl 3): 80-85.
10. Fournier A, Oprisiu R, Hottelart Y, Yvernaud PH, Ghazali A, Atik A, Hedri H, Said S, Sechet A, Rasolombololona M, Abighanem O, Sarraj A, El Esper N, Moriniere P, Boudailliez B, Westeel PF, Achard JM, Pruna A. Renal osteodystrophy in dialysis patients: diagnosis and treatment. Artif Organs. 1998; 22: 530-557.
11. Hein G, Franke S, Müller A, Bräunig E, Eidner T, Stein G. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis. Clin Rheumatol Invest. 1997; 16: 167-172.
12. 3 and radiology in end-stage renal disease. Kidney Int. 1993; 44: 1071-1077.
13. K/DOQI Clinical Practice Guidelinesfor Chronic Kidney Disease. Evaluation, classification and stratification. Am J Kidney Dis. 2002; 39: 1-266.
14. Kaye M, Hodsman AB, Malynowsky L. Staining of bone aluminum: use of acid Solochrome azurine. Kidney Int. 1990; 37: 1142-1147.
15. Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) assessed by bone histomorphometry. Kidney Int. 2005; 68: 1206-1214.
16. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol. 2004; 15: 1943-1951.
17. Malluche H, Ritz E, Lange HP, Kutschera J, Hodgson M, Seifert U, Schoeppe W. Bone histology in incipient and advanced renal failure. Kidney Int. 1976; 9: 355-362.
18. Malluche HH, Monier-Faugere MC. Atlas of Mineralized Bone Histology. New York: Karger; 1986.
19. Malluche HH, Monier-Faugere MC. The role of bone biopsy in the management of patients with renal osteodystrophy. J Am Soc Nephrol. 1994; 4: 1631-1642.
20. 3. Kidney Int. 1976; 9: 467-474.
21. Merz WA, Schenk RK. Quantitative structural analysis of human cancellous bone. Acta Anat (Basel). 1970; 75: 54-66.
22. Moe S. Vascular calcification and renal osteodystrophy relationship in chronic kdieny disease. Eur J Clin Invest. 2006; 36 (Suppl. 2): 51-62.
23. Moe S, Drüeke T Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G. Definition, evaluation and classification of renal osteodystrophy: a position statement for Kidney Disease: Improving global Outcomes (KDIGO). Kidney Int. 2006; 69: 1945-1953.
24. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche HH, Meunier PJ, Ott SM, Recker RP. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
25. Parfitt AM. A structural approach to renal bone disease. J Bone Miner Res. 1998; 13: 1213-1220.
26. Parker CR, Blackwell P, Freemont AJ, Hosking DJ. Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women. Am J Kidney Dis. 2002; 40: 385-369.
27. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab. 1992; 75: 145-150.
28. Qi Q, Momer-Faugere MC, Geng Z, Malluche HH. Predictive value of serum parathyroid serum levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis. 1995; 26: 622-631.
29. Romeis B. Mikroskopische Technik 17th ed. Baltimore: Urban and Schwarzenberg; 1989. p. 400.
30. Schmidt-GaykH, Drüeke T, Ritz E. Noninvasive circulating indicators of bone metabolism in uremic patients: can they replace bone biopsy? Nephrol Dial Transplant. 1996; 11: 415-418.
31. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endicrinol Metab. 2004; 89: 4246-4253.
32. Schulz W, Delling G, Büchel CG, Heidler R, Schulz A, Gessler U. Clincial and histological correlation of renal osteopathy. Verb Dtsch Ges hin Med. 1974; 80: 738-743.
33. Sheehan DC, Hrapchak BB. Theory and Practice of Histopathology (2nd ed). Columbus, Ohio: Battelle Press; 1987.
34. Wang M, Herczs G, Sherrad DJ, Maloney NA, Segre GV, Pei Y. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis. 1995; 26: 836-844.